U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503002) titled 'Shortened LSD Intervention for Major Depressive Disorder' on March 25.
Brief Summary: The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Major Depression Moderate
Major Depression Severe
Major Depression
Intervention:
DRUG: LSD + Risperidone
Participants will be administered LSD followed 45-minutes later by risperidone.
Recruitment Status: NOT_YET_RECRUITING
Sponsor...